Medicare

Dupixent® (dupilumab) Approved as the First-ever Biologic Medicine in Japan for Patients with Chronic Obstructive Pulmonary Disease (COPD)

Following recent approvals in the EU, China and the U.S., this approval was based on pivotal Phase 3 results in...

Quipt Home Medical Unveils Strategic Priorities for 2025 to Enhance Shareholder Value and Announces Voting Results from its Annual General Meeting

Company Optimizing Capital Allocation Strategy, Expanding De Novo Locations, Deepening Referral Networks, and Advancing a Healthcare System Focused M&A StrategyCINCINNATI,...

Hospital Information Systems Market worth US$116.75 billion by 2030 with 10.6% CAGR | MarketsandMarkets™

DELRAY BEACH, Fla., March 21, 2025 /PRNewswire/ -- The global Hospital Information Systems Market, valued at US$58.13 billion in 2023, is...

error: Content is protected !!